Delivery Order SPE2DB22D9239-SPE2DB24FDH70
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,764.88, is for the delivery of 420 mg/14 ml vials of the drug Perjeta. The delivery order has a completion date of December 18, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to supply the pharmaceutical product Perjeta 420 mg/14 ml vial. The order has a potential value of $8,277.00 and a completion date of January 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $25,529.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563969889 - Perjeta 420 mg/14 ml vial, 14 ml, with a performance period through April 1, 2024. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24FSW68 with DLA, which has a ceiling value of up to...
- This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $8,509.92 contract is for the supply of Perjeta 420 mg/14 ml vials, with an ultimate completion date of April 12, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract with DLA valued at up to $4,999,999 through 2025, enabling the issuance of firm-fixed-price delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $36,458.16, is for the delivery of Perjeta 420 mg/14 ml vial, a prescription medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty thousand six hundred ninety-two dollars and fifty cents ($20,692.50) by the Defense Logistics Agency to provide Perjeta 420 mg/14 ml vials. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. As a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $17,019.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563691587 PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical products. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, which has a potential value of up to $4,999,999 and enables the agency to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,229.08 to DMS Pharmaceutical Group Inc. on August 19, 2025, for the supply of Perjeta 420 mg/14 mL vials. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, will be performed at the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $54.7K by the Defense Logistics Agency for the supply of Perjeta 420 mg/14 mL vials. The contract, awarded on July 30, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $25,529.76 contract is for the delivery of Perjeta, a 420 mg/14 ml vial oncology medication, with a period of performance through April 9, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB, a single-award contract valued up to...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDH70Delivery Order
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $34,039.68, is for the delivery of the pharmaceutical product Perjeta (420 mg/14 ml vial, 14 ml) with a completion date of April 19, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, for a broad range of pharmaceutical supplies to military health facilities. This delivery order does not have a set-aside designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that has provided a variety of branded and generic drugs, biologics, and medical supplies to government agencies, particularly the Department of Veterans Affairs and the Department of Defense, through prime and subcontracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 3/29/24 |